Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon claims use of AIT-082 and other neurotrophic factor enhancers in ophthalmic disorders

July 5, 2000

New market launch for Azopt

June 30, 2000

Dura to launch second Allergan product

June 20, 2000

Alcon discovers utility of glutamate antagonists for retinal disorders

June 9, 2000

Allergan and Xoma expand rBPI ophthalmic program

June 6, 2000

Visudyne therapy receives Canadian approval for treatment of wet AMD

June 2, 2000

Angiotech signs license agreement with Alcon for delivery of paclitaxel

May 30, 2000

Early use of PDT with verteporfin in age-related macular degeneration

May 24, 2000

New agents for cataracts designed by Sankyo

May 22, 2000

Squalamine demonstrates preclinical activity in retinopathy

May 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...